Biological & pharmaceutical bulletin · 2025
Pharmacological Characteristics of Extracellular Ca2+ Influx Pathways Responsible for Platelet-Activating Factor-Induced Contractions in Rat Esophagus Smooth Muscle: Involvement of L-Type, Receptor-Operated, and Store-Operated Ca2+ Channels.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Obara Keisuke, Takahashi Sana, Otake Miho, Fujiwara Mako, Kato Daiki, Tanaka Momoko, Ura Tomohiro, Yamashita Mio, Murata Azusa, Yoshioka Kento, Kusakabe Taichi, Takahashi Keisuke, Kato Keisuke, Tanaka Yoshio
Аннотация
We examined the contribution of L-type voltage-dependent Ca2+ channels (VDCCs) and non-VDCCs to platelet-activating factor (PAF)-induced contractions of rat esophageal smooth muscle (ESM). We also attempted to obtain more detailed information about the non-VDCC molecules involved in the PAF effect. PAF (10-6 M)-induced contractions were abolished in Ca2+-free solution containing ethylene glycol-bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid and were attenuated by diltiazem (10-5 M), a VDCC inhibitor. PAF-induced contractions in the presence of diltiazem were inhibited by approx. 50% by LOE-908 (3 × 10-5 M), an inhibitor of receptor-operated Ca2+ channels (ROCCs), and were strongly inhibited by LOE-908 plus SKF-96365 (3 × 10-5 M), an inhibitor of both ROCCs and store-operated Ca2+ channels (SOCCs). The contribution of each Ca2+ channel was estimated to be approx. 25% for VDCCs, approx. 30% for ROCCs, and approx. 35% for SOCCs. Among the non-VDCC-related molecular candidates examined in rat ESM, Trpv4, Trpc6, and Trpc3 were abundant ROCC-related mRNAs, and Orai1 was the most abundant SOCC-related mRNAs. However, PAF-induced contractions in the presence of diltiazem were not significantly inhibited by combination treatment with putative inhibitors of transient receptor potential V4 (TRPV4) (GSK 2193874, 3 × 10-7 M), TRPC6 (SAR7334, 10-6 M), and TRPC3 (Pyr10, 3 × 10-5 M). In contrast, PAF-induced contractions in the presence of both diltiazem and LOE-908 were completely inhibited by Synta66 (10-5 M), an Orai1 inhibitor, which also inhibited PAF-induced contractions by approx. 30% in the absence of Ca2+ channel inhibitors. These findings indicate that PAF-induced rat ESM contractions depend on extracellular Ca2+ influx through VDCCs, ROCCs, and SOCCs, with Orai1 being the key SOCC molecule.